Akero Therapeutics Announces $70 Million in New Financing to Advance Therapeutic Pipeline for NASH, Serious Metabolic Diseases

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2RPFfXw
via IFTTT